Detalles de la búsqueda
1.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994196
2.
Testing the efficacy of real-time fMRI neurofeedback for training people who smoke daily to upregulate neural responses to nondrug rewards.
Cogn Affect Behav Neurosci
; 23(2): 440-456, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788202
3.
The association between perinatal hypoxia exposure and externalizing symptoms and children's decision making in conditions of uncertainty is moderated by DRD2 genotype.
Dev Psychobiol
; 61(1): 56-68, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30264459
4.
Decision-making in uncertain contexts: The role of autonomic markers in resolving indecision.
Int J Psychophysiol
; 177: 220-229, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640857
5.
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial.
RMD Open
; 8(2)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35850974
Resultados
1 -
5
de 5
1
Próxima >
>>